Analytical Data
-
Gene name
MHT1
- Application
-
Alternative Names
S-methylmethionine:homocysteine methyltransferase 1 ;SMM:Hcy S-methyltransferase 1
-
Species
Saccharomyces cerevisiae
-
Source
E. coli
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q12525
-
Expression Region
1-324aa
-
Molecular Weight
40.7 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MHT1 recombinant protein has garnered significant attention in the field of molecular biology and biotechnology due to its potential applications in various research and therapeutic areas. This protein, derived from the MHT1 gene, plays a critical role in cellular processes such as metabolic regulation and stress response. Understanding its structure and function can provide insights into cellular mechanisms and disease pathways, particularly in conditions where MHT1 is implicated, such as metabolic disorders and cancer. Researchers have utilized recombinant DNA technology to produce MHT1 in host organisms, enabling detailed studies of its characteristics and interactions. The production of MHT1 as a recombinant protein allows for easier manipulation and characterization, paving the way for its use in developing diagnostic tools and novel therapeutic strategies. Furthermore, investigating the post-translational modifications and biological activities of MHT1 can reveal new dimensions of its functionality within cells, opening avenues for innovative treatments targeting specific pathways. Overall, the study of MHT1 recombinant protein is a promising area of research that could lead to improved understanding and management of complex biological systems and diseases.
